Shantha Biotechnics' Corporate Majority Round

Shantha Biotechnics raised a round of funding on July 28, 2009. Investors include Sanofi Pasteur.

Shantha Biotech is engaged in the production and commercialization of vaccines against Hepatitis B, Tetanus, Diphtheria, Pertussis, Haemophilus Influenza Type B, and Cholera, as well as recombinant Er…

Articles about Shantha Biotechnics' Corporate Majority Round: